Basant Kumar Thakur

Dr. Basant Kumar Thakur

Department of Pediatric Hematology and Oncology, University Hospital Essen, Hufelandstraße 55, D-45147, Essen, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2021 in Cancer and Metastasis Reviews
Verified
Journal Article
Open access
PDF file
LBLennart Barthel
Lennart Barthel
MHMartin Hadamitzky
Martin Hadamitzky
PDPhilipp Dammann
Philipp Dammann
MSManfred Schedlowski
Manfred Schedlowski
Ulrich SureUlrich Sure
Ulrich Sure
SHSusann Hetze
Susann Hetze
In patients with glioblastoma, the average survival time with current treatments is short, mainly due to recurrences and resistance to therapy. This insufficient treatment success is, in large parts, due to the tremendous molecular heterogeneity of gliomas, which affects the overall prognosis and response to therapies and plays a vital role in gliomas’ grading. In addition, the tumor microenvironment is a major player for glioma development and resistance to therapy. Active communication between glioma cells and local or neighboring healthy cells and the immune environment promotes the cancerogenic processes and contributes to establishing glioma stem cells, which drives therapy resistance. Besides genetic alterations in the primary tumor, tumor-released factors, cytokines, proteins, extracellular vesicles, and environmental influences like hypoxia provide tumor cells the ability to evade host tumor surveillance machinery and promote disease progression. Moreover, there is increasing evidence that these players affect the molecular biological properties of gliomas and enable inter-cell communication that supports pro-cancerogenic cell properties. Identifying and characterizing these complex mechanisms are inevitably necessary to adapt therapeutic strategies and to develop novel measures. Here we provide an update about these junctions where constant traffic of biomolecules adds complexity in the management of glioblastoma. Graphical abstract

28 March 2022 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
JGJamal Ghanam
Jamal Ghanam
VCVenkatesh Kumar Chetty
Venkatesh Kumar Chetty
LBLennart Barthel
Lennart Barthel
DRDirk Reinhardt
Dirk Reinhardt
PHPeter-Friedrich Hoyer
Peter-Friedrich Hoyer
Basant Kumar ThakurBasant Kumar Thakur
Basant Kumar Thakur
Extracellular vesicle (EV) secretion is a highly conserved evolutionary trait in all organisms in the three domains of life. The packaging and release of EVs appears to be a bulk-flow process which takes place mainly under extreme conditions. EVs participate in horizontal gene transfer, which supports the survival of prokaryotic and eukaryotic microbes. In higher eukaryotes, almost all cells secrete a heterogeneous population of EVs loaded with various biomolecules. EV secretion is typically higher in cancer microenvironments, promoting tumor progression and metastasis. EVs are now recognized as additional mediators of autocrine and paracrine communication in health and disease. In this context, proteins and RNAs have been studied the most, but extracellular vesicle DNA (EV-DNA) has started to gain in importance in the last few years. In this review, we summarize new findings related to the loading mechanism(s), localization, and post-shedding function of EV-DNA. We also discuss the feasibility of using EV-DNA as a biomarker when performing a liquid biopsy, at the same time emphasizing the lack of data from clinical trials in this regard. Finally, we outline the potential of EV-DNA uptake and its interaction with the host genome as a promising tool for understanding the mechanisms of cancer evolution.

12 January 2023 in Small
Verified
Journal Article
Open access
JGJamal Ghanam
Jamal Ghanam
VCVenkatesh Kumar Chetty
Venkatesh Kumar Chetty
XZXingfu Zhu
Xingfu Zhu
XLXiaomin Liu
Xiaomin Liu
MGMárton Gelléri
Márton Gelléri
Basant Kumar ThakurBasant Kumar Thakur
Basant Kumar Thakur
Small extracellular vesicles (sEVs) are 30–200 nm nanovesicles enriched with unique cargoes of nucleic acids, lipids, and proteins. sEVs are released by all cell types and have emerged as a critical mediator of cell‐to‐cell communication. Although many studies have dealt with the role of sEVs in health and disease, the exact mechanism of sEVs biogenesis and uptake remain unexplored due to the lack of suitable imaging technologies. For sEVs functional studies, imaging has long relied on conventional fluorescence microscopy that has only 200–300 nm resolution, thereby generating blurred images. To break this resolution limit, recent developments in super‐resolution microscopy techniques, specifically single‐molecule localization microscopy (SMLM), expanded the understanding of subcellular details at the few nanometer level. SMLM success relies on the use of appropriate fluorophores with excellent blinking properties. In this review, the basic principle of SMLM is highlighted and the state of the art of SMLM use in sEV biology is summarized. Next, how SMLM techniques implemented for cell imaging can be translated to sEV imaging is discussed by applying different labeling strategies to study sEV biogenesis and their biomolecular interaction with the distant recipient cells.

3 December 2024 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
IWInbal Wortzel
Inbal Wortzel
YSYura Seo
Yura Seo
IAIfe Akano
Ife Akano
LSLee Shaashua
Lee Shaashua
GTGabriel Cardial Tobias
Gabriel Cardial Tobias
DLDavid Lyden
David Lyden

Verified
Journal Article
Open access
PDF file
MDMarvin Droste
Marvin Droste
TTTobias Tertel
Tobias Tertel
SJStefanie Jeruschke
Stefanie Jeruschke
RDRobin Dittrich
Robin Dittrich
EKEvangelia Kontopoulou
Evangelia Kontopoulou
BGBernd Giebel
Bernd Giebel
Small extracellular vesicles isolated from urine (uEVs) are increasingly recognized as potential biomarkers. Meanwhile, different uEV preparation strategies exist. Conventionally, the performance of EV preparation methods is evaluated by single particle quantification, Western blot, and electron microscopy. Recently, we introduced imaging flow cytometry (IFCM) as a next-generation single EV analysis technology. Here, we analyzed uEV samples obtained with different preparation procedures using nanoparticle tracking analysis (NTA), semiquantitative Western blot, and IFCM. IFCM analyses demonstrated that urine contains a predominant CD9+ sEV population, which exceeds CD63+ and CD81+ sEV populations. Furthermore, we demonstrated that the storage temperature of urine samples negatively affects the recovery of CD9+ sEVs. Although overall reduced, the highest CD9+ sEV recovery was obtained from urine samples stored at −80 °C and the lowest from those stored at −20 °C. Upon comparing the yield of the different uEV preparations, incongruencies between NTA and IFCM data became apparent. Results obtained by both NTA and IFCM were consistent with Western blot analyses for EV marker proteins; however, NTA results correlated with the amount of the impurity marker uromodulin. Despite demonstrating that the combination of ultrafiltration and size exclusion chromatography appears as a reliable uEV preparation technique, our data challenge the soundness of traditional NTA for the evaluation of different EV preparation methods.

13 January 2020 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
EKEvangelia Kontopoulou
Evangelia Kontopoulou
SSSarah Strachan
Sarah Strachan
KRKatarina Reinhardt
Katarina Reinhardt
FKFabienne Kunz
Fabienne Kunz
CWChristiane Walter
Christiane Walter
Basant Kumar ThakurBasant Kumar Thakur
Basant Kumar Thakur